These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27453478)

  • 1. Targeting mTOR signaling by polyphenols: A new therapeutic target for ageing.
    Pazoki-Toroudi H; Amani H; Ajami M; Nabavi SF; Braidy N; Kasi PD; Nabavi SM
    Ageing Res Rev; 2016 Nov; 31():55-66. PubMed ID: 27453478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coming of age: molecular drivers of aging and therapeutic opportunities.
    Newgard CB; Sharpless NE
    J Clin Invest; 2013 Mar; 123(3):946-50. PubMed ID: 23454756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond.
    Lamming DW
    Cold Spring Harb Perspect Med; 2016 May; 6(5):. PubMed ID: 27048303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.
    Blagosklonny MV
    Cell Cycle; 2006 Sep; 5(18):2087-102. PubMed ID: 17012837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From rapalogs to anti-aging formula.
    Blagosklonny MV
    Oncotarget; 2017 May; 8(22):35492-35507. PubMed ID: 28548953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOR Signaling Pathway in Cardiac Aging and Heart Failure.
    Daneshgar N; Rabinovitch PS; Dai DF
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33513917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease.
    Johnson SC
    Subcell Biochem; 2018; 90():49-97. PubMed ID: 30779006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapalogs in cancer prevention: anti-aging or anticancer?
    Blagosklonny MV
    Cancer Biol Ther; 2012 Dec; 13(14):1349-54. PubMed ID: 23151465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapalogs and mTOR inhibitors as anti-aging therapeutics.
    Lamming DW; Ye L; Sabatini DM; Baur JA
    J Clin Invest; 2013 Mar; 123(3):980-9. PubMed ID: 23454761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating mTOR in aging and health.
    Johnson SC; Sangesland M; Kaeberlein M; Rabinovitch PS
    Interdiscip Top Gerontol; 2015; 40():107-27. PubMed ID: 25341517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic mechanistic target of rapamycin inhibition: preventing cancer to delay aging, or vice versa?
    Sharp ZD; Curiel TJ; Livi CB
    Interdiscip Top Gerontol; 2013; 38():1-16. PubMed ID: 23503511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration.
    Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1883-7. PubMed ID: 19448395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Rapamycin a Dietary Restriction Mimetic?
    Unnikrishnan A; Kurup K; Salmon AB; Richardson A
    J Gerontol A Biol Sci Med Sci; 2020 Jan; 75(1):4-13. PubMed ID: 30854544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin: one drug, many effects.
    Li J; Kim SG; Blenis J
    Cell Metab; 2014 Mar; 19(3):373-9. PubMed ID: 24508508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative idiosyncrasies in life extension by reduced mTOR signalling and its distinctiveness from dietary restriction.
    Garratt M; Nakagawa S; Simons MJ
    Aging Cell; 2016 Aug; 15(4):737-43. PubMed ID: 27139919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing healthy lifespan by suppressing aging in our lifetime: preliminary proposal.
    Blagosklonny MV
    Cell Cycle; 2010 Dec; 9(24):4788-94. PubMed ID: 21150328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration.
    Mazucanti CH; Cabral-Costa JV; Vasconcelos AR; Andreotti DZ; Scavone C; Kawamoto EM
    Curr Top Med Chem; 2015; 15(21):2116-38. PubMed ID: 26059361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From growing to secreting: new roles for mTOR in aging cells.
    Pani G
    Cell Cycle; 2011 Aug; 10(15):2450-3. PubMed ID: 21720215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
    Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
    Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting mTOR Signaling by Dietary Polyphenols in Obesity Prevention.
    Cao Y; Han S; Lu H; Luo Y; Guo T; Wu Q; Luo F
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.